Figure 4. T/HS increases cysteinyl leukotriene production.
Cysteinyl leukotrienes increase sequentially after T/HS when compared to Control and T/SS (*, p < 0.05). MK-886 administration prior to induction of hemorrhage decreases the amount of leukotriene produced when compared to T/HS+Vehicle (**, p < 0.05).